- On a preliminary basis, Natus Medical (BABY +4.8%) expects Q4 revenues of $107.5 - 108.0M and $381.2M - 383.2M for 2016, both in line with consensus.
- 2017 guidance: revenues: $505.0M - 510.0M (consensus: $428.0M); non-GAAP EPS: $1.80 - 1.85 (consensus: $1.85).
- Q1 guidance: revenues: $122.0M - 124.0M; non-GAAP EPS: $0.32 - 0.34.
- Final 2016 results will be released before the open on February 1.
- $JPM17